Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-05FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for simvastatin, updating the approved generic product.
-
FDA approval · 2014-10-30FDA Approved: AMMONIA N-13 — Original Application (Brigham and Women's Hospital, Inc., The)
FDA approved Ammonia N-13 under an original application from Brigham and Women's Hospital for use as a radiopharmaceutical in PET myocardial…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Comprehensive Evaluation of Ischemic Heart Disease Using MRI [Phase 2, Phase 3]
Update on a Phase 2/Phase 3 clinical trial evaluating MRI-based evaluation of ischemic heart disease, with results posted in 2014.
-
FDA approval · 2014-08-19FDA Approved: AMMONIA N 13 — Original Application (The Johns Hopkins University)
FDA approved AMMONIA N 13 (NH3N13) via an Original Application under an ANDA from The Johns Hopkins University, for use as a radiopharmaceut…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population
This clinical trial update reports on the prevalence and level of thienopyridine (antiplatelet) resistance in patients undergoing percutaneo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training [NA]
This clinical trial update reports the completion of a Copenhagen study comparing a low-energy diet to interval training in obese patients w…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial [Phase 4]
This document reports the completion of the Phase 4 MetCAB trial evaluating metformin in patients undergoing coronary artery bypass graft su…
-
FDA approval · 2014-07-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease [Phase 4]
Phase 4 clinical trial evaluating integrated cardiac imaging for ischemic heart disease has completed and posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: By Pass Surgery With Stem Cell Therapy in Chronic Ischemic Cardiopathy [Phase 2]
Phase 2 clinical trial evaluating bypass surgery with stem cell therapy for chronic ischemic heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Cardiac-CT in the Treatment of Acute Chest Pain [NA]
This entry reports the completion of a clinical trial evaluating Cardiac-CT for acute chest pain in patients with ischemic heart disease. No…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial) [Phase 2]
Phase 2 trial update reporting completion of mesenchymal stromal cell therapy (MyStromalCell) in patients with chronic ischemic heart diseas…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)
This clinical trial update reports the completion of a study examining the roles of heavy metals, angiogenesis factors, and osteopontin in i…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI) [Phase 2]
Phase II trial of a combination stem cell therapy for severe coronary ischemia has been suspended.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof [Phase 3]
Phase 3 study evaluating intravenous iron isomaltoside 1000 (Monofer) given by infusion to non-anaemic patients undergoing cardiac surgery (…
-
FDA approval · 2014-04-11FDA Approved: CLOPIDOGREL — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for clopidogrel, enabling a generic version of the antiplatelet medicatio…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Women's Ischemia Syndrome Evaluation (WISE) [Phase 3]
Clinical trial update indicating the Phase 3 Women's Ischemia Syndrome Evaluation (WISE) study has completed.
-
FDA label_change · 2014-03-29FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental labeling change for Lexiscan (regadenoson) from Astellas Pharma US, updating the product labeling.
-
FDA approval · 2014-03-28FDA Approved: AMMONIA N 13 — Original Application (UCSF Radiopharmaceutical Facility)
The FDA approved Ammonia N-13 (NH3N13) from the UCSF Radiopharmaceutical Facility under an Original Application.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) [Phase 4]
Phase 4 trial comparing the Endeavor zotarolimus-eluting stent with the Cypher sirolimus-eluting stent in patients with ischemic heart disea…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: The Israeli MGuard Registry
The Israeli MGuard Registry, sponsored by InspireMD, has completed a clinical trial evaluating the MGuard stent system for conditions includ…
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).
-
CLINICAL_TRIALS research · 2014-03-04Clinical Trial Update: Rapid Early Action for Coronary Treatment (REACT) [Phase 3]
Phase 3 clinical trial update for Rapid Early Action for Coronary Treatment (REACT) has completed, with no results provided in the document.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Stress and Ischemic Heart Disease. The Effect of Bio Feedback Guided Stress Management on Life Quality Including Signs of Depression and Stress [NA]
This completed clinical trial evaluated whether biofeedback-guided stress management improves quality of life and reduces signs of depressio…
-
CLINICAL_TRIALS research · 2014-02-20Clinical Trial Update: Epidemiology of Breast Arterial Calcification
This completed Mayo Clinic trial update examines the epidemiology of breast arterial calcification and its relation to coronary artery disea…